International Urology and Nephrology

Aims & Scope

International Urology and Nephrology publishes original papers, as well as reviews of literature on interesting topics in the fields of urology and nephrology.

The Journal provides a forum for scientific discourse on all renal and urologic disorders.

The nephrology section of the Journal includes clinical nephrology, renal replacement therapy (dialysis and transplantation), experimental and translational nephrology.

Interesting and novel case reports and case series are considered for publication as letters to the editor.

Adult and geriatric nephrology are the areas of primary coverage.

The urology section welcomes manuscripts in general and pediatric urology as well as all urologic sub-specialties.

The main thrust of the publication is in significant observations in clinical urology and translational research but will consider reports in significant basic science research.

Review articles, book reviews and letters to the editor are welcome.

Case reports will only be considered in the form of letters to the editor.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.9
2024	1.80

SJR (SCImago Journal Rank)

Year	Value
2024	0.577

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	69

Journal Rank

Year	Value
2024	10056

Journal Citation Indicator

Year	Value
2024	2101

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection

  Citation: 399

  Authors: Brandon Michael, Giuseppe

• Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions

  Citation: 250

  Authors: Mehmet, Adem, Yusuf, Bunyamin, Faruk, Nuket, Ebru, Ali, Ramazan, Adrian

• Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease

  Citation: 210

  Authors: Mehmet, Yalcin, Hilmi Umut, Yasemin Gulcan, Mahmut, Hakki, Murat, Yusuf, Tayfun, Abdulgaffar, Adrian, David, Osman, Mahmut Ilker

• Zinc in the human prostate gland: Normal, hyperplastic and cancerous

  Citation: 187

  Authors: V. Ye., T. V., S. V.

• Magnesium metabolism in health and disease

  Citation: 173

  Authors: Carlos G.

• NGAL: a biomarker of acute kidney injury and other systemic conditions

  Citation: 169

  Authors: Sachin S., Dinna, Ilona, Chang Yin, Federico, Paolo, Massimo, Valentina, Grazia, Claudio

• Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study

  Citation: 159

  Authors: Pradeep, Derek, Ruben, Naoki, Kenneth, Yoram, Michael

• Unilateral ureteral obstruction: beyond obstruction

  Citation: 155

  Authors: Alvaro C., Alberto, Maria C., Maria D., Ana B., Adrian M., Sergio, Marta, Jesus, Alberto

• Speedy elimination of ureterolithiasis in lower part of ureters with the alpha 1-blocker – Tamsulosin

  Citation: 146

  Authors: I., J., J., M., J., P.

• Novel acute kidney injury biomarkers: their characteristics, utility and concerns

  Citation: 133

  Authors: Braian M., Mateo G., Cecilia, Carlos G.

---